*Interfaculty Initiative in Health Policy, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA
†Division of General Medicine, Department of Internal Medicine, and Department of Health Management and Policy
‡Center for Value-Based Insurance Design; University of Michigan, Ann Arbor, MI
§Department of Health Care Policy, Harvard Medical School, Boston, MA
∥Medical Affairs Managed Markets, AstraZeneca Pharmaceuticals, Wilmington, DE
¶Health Alliance Medical Plans, Urbana, IL
This project was supported, in part, by an unrestricted grant from AstraZeneca to Harvard Medical School.
M.E.C. and A.M.F. have relevant and material financial relationships with the following companies: Abbott, AstraZeneca, Genentech, Pfizer Inc., Sanofi-aventis, TriZetto, and the VBID Institute. M.E.C. also has a relationship with Johnson & Johnson; A.M.F. with Eli Lilly, GlaxoSmithKline, Health Alliance Medical Plans, Merck and Co., and Novartis. A.Z. is employed by AstraZeneca. N.H. and S.L. are employed by Health Alliance Medical Plans. M.B.F. and Y.H. declare no conflict of interest.
Reprints: Matthew B. Frank, BA, Interfaculty Initiative in Health Policy, Graduate School of Arts and Sciences, Harvard University, 14 Story St, Cambridge, MA 02138. E-mail: [email protected].
